Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Study of Regenerative Cell Therapy in Treating Diabetic Patients With Critical Limb Ischemia

NCT00872326 is registered in ClinicalTrials.gov with Andalusian Network for Design and Translation of Advanced Therapies as lead sponsor.

NCT NCT00872326
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00872326 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Study of Regenerative Cell Therapy in Treating Diabetic Patients With Critical Limb Ischemia
Lead sponsor
Andalusian Network for Design and Translation of Advanced Therapies
Phase
Phase 1/2
Overall status
Completed
Start date
December 31, 2007
Completion date
May 31, 2009
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic foot, peripheral vascular diseases